st was positive. Cardiotocography (CTG) showed a standard pattern. The patient was hospitalized with CTG monitoring andDepartment of Obstetrics and Gynaecology, Leiden University MedicalCentre, Leiden, Netherlands; 2Department of Clinical Epidemiology, Leiden University Medical Centre, Leiden, Netherlands; 3Jon J. van Rood Centre for Clinical Transfusion Study, Sanquin Research, Leiden, Netherlands; Division of Obstetrics and Gynaecology, Erasmus University, Rotterdam, Netherlands; CaMK II Activator MedChemExpress 5Department of Obstetrics, Birth Center, Wilhelmina’s Youngsters Hospital, Division Lady and Baby, University Healthcare Center Utrecht, Utrecht, Netherlands; Athena Institute, VU University, Amsterdam, Netherlands; 7Department of Internal Medicine, Radboud University Nijmegen Health-related Center, Nijmegen, Netherlands; 8Department of Obstetrics and Gynecology, Deventer Hospital, Deventer, Netherlands;9 6National Perinatal Epidemiology Unit, University of Oxford, Oxford,United kingdom Background: Placenta accreta spectrum disorder (PAS) features a high maternal morbidity and mortality price caused by severe postpartum haemorrhage. The role of prophylactic endovascular interventions to cut down blood loss in these sufferers is controversial.ABSTRACT969 of|started cefuroxime for acute pyelonephritis. Prophylactic enoxaparin was started around the 2nd day. The patient remained clinically stable, analytically highlighting a progressive reduce in Computer in the 2nd day on. Around the 4th day of hospitalization with thrombocytopenia of 11×109/L and sFlt-1/PlGF ratio ongoing, a variety of different diagnosis had been raised: pre-eclampsia, HELLP syndrome, heparin induced thrombocytopenia (HIT) or COVID-19-induced thrombocytopenia. Final results:Mg2+ compound collection tubes. Around the 5th day she was discharged. The delivery happened later, at 39 weeks of gestation. Conclusions: The identification of a pseudothrombocytopenia avoided an iatrogenic preterm labour. When confronted using a patient with no signs or symptoms of bleeding or haemorrhagic dyscrasia and no previous history of thrombocytopenia, pseudothrombocytopenia ought to be deemed. Its early detection may well stay clear of substantial investigations and unnecessary therapeutic procedures.PB1314|The Effect of Prothrombin Complex COX-1 Inhibitor web Concentrate and Cryoprecipitate on the Frequency and Severity of Numerous Organ Dysfunction Syndrome in Massive Obstetric Haemorrhage V. Sedinkin; O. Klygunenko; O. Volkov Dnipropetrovsk Medical Academy of Overall health Ministry of Ukraine, Dnipro, Ukraine Background: Effective therapy of massive obstetric haemorrhage is significant; however, the optimal therapy is still not known. Aims: We aimed to compare the efficacy of first-line therapy employing cryoprecipitate (CP) or prothrombin complex concentrate (PCC) for the reversal of induced coagulopathy, and consequently the improvement of several organ dysfunction syndrome (MODS). Strategies: Having agreed with all the nearby Ethics Committee and obtained the informed consents, 75 women (whose delivery or early postpartum period was complex by serious hemorrhage with blood volume (BV) deficit of 402 ) were examined. Patients were randomized into two groups depending on the qualities of your BV replenishment. Both groups have been comparable in relation to age, height, gestation term, blood loss volume (257010 ml). In 1 group (n = 42) of first-line prevention of progression extreme coagulopathy using CP (five U). In group 2 (n = 33), the first-line drug was utilized for 1500 IU (20 mg / kg) PCC. Clinical signs o
